Cell-Based Immunotherapies

- 基于细胞的免疫疗法 -

New for 2020, The Cell-Based Immunotherapy stream focuses on the latest protein engineering, clinical and analytical strategies driving the development of cell-based immunotherapies such as CAR Ts, TCRs, TILs and NKs, for the treatment of cancer and immune disorders. Topics include improving target identification, optimizing product design, specificity, safety, characterization and analytics.

Conferences Include:

5月4 - 5日

Improving Immunotherapy Efficacy and Safety
( 提升免疫疗法有效性和安全性 )

5月6 - 7日

CAR Ts, TCRs and TILs
( CAR-T、TCR、TIL )

5月7 - 8日

Cell and Gene Therapy Analytics
( 细胞疗法和基因疗法分析 )


Keynote Speakers:

 

Prasad Adusumilli, MD, FACS, FCCP Deputy Chief and Associate Attending, Thoracic Surgery; Director, Mesothelioma


Adrian Bot, PhD Vice President, Translational Medicine, Kite Pharma, a Gilead Company


Jan Joseph (Jos) Melenhorst, PhD Adjunct Associate Professor, Pathology & Laboratory Medicine, University of Pennsylvania


Jeffrey Miller, MD Professor of Medicine, Deputy Director, Masonic Cancer Center, Division of Hematology, Oncology and Transplantation, University of Minnesota

Choose your language
Chinese
Japanese
Korean
English





显示切换



免费电子邮件通知服务